#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Multiple sclerosis, a treatable disease."
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Yojana Gadiya"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/conso
# --------------------------------------------------------
 DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns"
# DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns"
# DEFINE NAMESPACE DOID           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns"
# DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns"
 DEFINE NAMESPACE EFO            AS URL "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns"
# DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns"
 DEFINE NAMESPACE CONSO          AS URL "https://raw.githubusercontent.com/pharmacome/conso/0816cb6686751420365441adc6a28ced2d272f14/export/conso-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns"
 DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns"
 DEFINE NAMESPACE HP             AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hp-names.belns"
 DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns"
# DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns"
 DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/conso/0816cb6686751420365441adc6a28ced2d272f14/external/mesh-names.belns"
# DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/conso/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
# DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/mirbase-names.belns"
 DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ncbigene.belns"
# DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/pfam-names.belns"
# DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/conso/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
# DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
 DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
 DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
 DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
 DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
 DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
 DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
 DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
 DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
 DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
 DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
 DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
 DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
 DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
 DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
 DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############
SET Citation = {"PubMed", "27956442"}

SET Evidence = "MS is an inflammatory disease of the central nervous system (CNS), which causes a heterogeneous array of symptoms and signs because of differential involvement of motor, sensory, visual and autonomic systems."
path(MESH:"Multiple Sclerosis") isA path(MESH:"Central Nervous System Diseases")
path(MESH:"Multiple Sclerosis") -- path(MESH:Inflammation)
path(MESH:"Multiple Sclerosis") -- a(MESH:"Motor Neurons")
path(MESH:"Multiple Sclerosis") -- path(MESH:Sensation)
path(MESH:"Multiple Sclerosis") -- path(MESH:"Autonomic Nervous System")

SET Evidence = "Optic neuritis (inflammation of the optic nerve), Uhthoff's phenomenon (transient fluctuation
or worsening of MS symptoms with a rise in body temperature) and Lhermitte's phenomenon (an abnormal electric-shock
like sensation down the spine or limbs on neck flexion) are characteristic of MS.[3–5]"
path(MESH:"Multiple Sclerosis") -- path(MESH:"Optic Neuritis")
path(MESH:"Multiple Sclerosis") -- path(MESH:"Body Temperature Changes")
path(MESH:"Multiple Sclerosis") -- path(HP:"Lhermitte's sign")

SET Evidence = "CIS encompasses an acute clinical attack affecting one or more CNS sites and can convert to relapsing remitting MS (RRMS)."
#Clinically isolated syndrome (CIS) - Demyelinating Diseases
path(MESH:"Demyelinating Diseases") neg path(MESH:"Central Nervous System")
path(MESH:"Demyelinating Diseases") -> path(MESH:"Multiple Sclerosis, Relapsing-Remitting")

######how to code tloc() across BBB
SET Evidence = "These early stages of MS with underlying demyelination are thought to have an inflammatory pathological substrate with migration of autoreactive lymphocytes across the blood-brain barrier."
#these - CIS and RRMS
path(MESH:"Demyelinating Diseases") -- path(MESH:Inflammation)
path(MESH:"Multiple Sclerosis, Relapsing-Remitting") -- path(MESH:Inflammation)
SET MeSHAnatomy = "Lymphocytes"
path(MESH:"Demyelinating Diseases") -> tloc(a(MESH:Lymphocytes), fromLoc(GO:cytoplasm), toLoc(MESH:"Blood-Brain Barrier"))
path(MESH:"Multiple Sclerosis, Relapsing-Remitting") -> bp(GO:"transport across blood-brain barrier")
UNSET MeSHAnatomy

####Change according to above sentence change.
SET Evidence = "This triggers a cascade of inflammation with T- and B-cell clonal expansion, and microglia activation and oxidative damage, mitochondrial injury and energy failure, leading to the
development of the characteristic plaque. [15,16]"
SET MeSHAnatomy = {"T-Lymphocytes", "B-Lymphocytes"}
bp(GO:"transport across blood-brain barrier") => path(CONSO:"Clonal Expansion")
path(CONSO:"Clonal Expansion") => path(MESH:Inflammation)
UNSET MeSHAnatomy
bp(GO:"transport across blood-brain barrier") => bp(GO:"microglial cell activation")
bp(GO:"microglial cell activation") => path(MESH:Inflammation)
bp(GO:"transport across blood-brain barrier") => path(MESH:"Oxidative Stress")
path(MESH:"Oxidative Stress") => path(MESH:Inflammation)
bp(GO:"transport across blood-brain barrier") => path(MESH:"Mitochondrial Diseases")
path(MESH:"Mitochondrial Diseases") => path(MESH:Inflammation)
bp(GO:"transport across blood-brain barrier") neg path(MESH:"Energy Metabolism")
path(MESH:"Energy Metabolism") neg path(MESH:Inflammation)
path(MESH:Inflammation) => path(CONSO:Plaque)

SET Evidence = "There is further axonal injury and atrophy in both white and grey matter, with a likely underlying
neurodegenerative pathogenesis, but less inflammation. [16,18]"
#in case of secondary progressive MS (SPMS) - Multiple Sclerosis, Chronic Progressive
SET MeSHAnatomy = {"White Matter", "Gray Matter"}
path(MESH:"Multiple Sclerosis, Chronic Progressive") => path(MESH:"Diffuse Axonal Injury")
path(MESH:"Multiple Sclerosis, Chronic Progressive") => path(MESH:Atrophy)
path(MESH:"Multiple Sclerosis, Chronic Progressive") -> path(MESH:Inflammation)
path(MESH:"Diffuse Axonal Injury") -> path(MESH:"Neurodegenerative Diseases")
path(MESH:Atrophy) -> path(MESH:"Neurodegenerative Diseases")
UNSET MeSHAnatomy

SET Evidence = "10–15% of patients have progressive disability from the outset, usually due to spinal cord disease. This is defined as primary progressive MS (PPMS). 1,3,20"
path(MESH:"Multiple Sclerosis, Chronic Progressive") => path(MESH:"Spinal Cord Diseases")
path(MESH:"Spinal Cord Diseases") -> path(EFO:"movement disorder")

SET Evidence = "Due to spinal cord dysfunction, patients often have a progressive spastic paraparesis."
path(MESH:"Spinal Cord Diseases") => path(MESH:"Paraparesis, Spastic")

SET Evidence = "The pathological basis appears to be more diffuse brain axonal loss and further microglial activation with atrophy."
path(MESH:"Paraparesis, Spastic") => path(MESH:"Diffuse Axonal Injury")
path(MESH:Atrophy) => bp(GO:"microglial cell activation")

SET Evidence = "There is anterograde and retrograde neurodegeneration with oxidative damage and energy failure."
path(MESH:"Oxidative Stress") -> path(MESH:"Amnesia, Anterograde")
path(MESH:"Oxidative Stress") -> path(MESH:"Amnesia, Retrograde")
path(MESH:"Energy Metabolism") -| path(MESH:"Amnesia, Anterograde")
path(MESH:"Energy Metabolism") -| path(MESH:"Amnesia, Retrograde")

SET Evidence = "Meta-analyses suggest that the strongest evidence of association is related to Epstein-Barr virus biomarker positivity, infectious mononucleosis and smoking. [21]"
#biomarker for MS
path(MESH:"Epstein-Barr Virus Infections") pos path(MESH:"Multiple Sclerosis")
path(MESH:"Infectious Mononucleosis") pos path(MESH:"Multiple Sclerosis")
path(MESH:Smoking) pos path(MESH:"Multiple Sclerosis")

SET Evidence = ""
